{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:30:55Z","timestamp":1773286255412,"version":"3.50.1"},"reference-count":29,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2003,4,29]],"date-time":"2003-04-29T00:00:00Z","timestamp":1051574400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J American Geriatrics Society"],"published-print":{"date-parts":[[2003,5]]},"abstract":"<jats:p>\n                    <jats:bold>OBJECTIVES:<\/jats:bold>\n                    To determine whether income influences evidence\u2010based medication use by older persons with diabetes mellitus in managed care who have the same prescription drug benefit.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>DESIGN:<\/jats:bold>\n                    Observational cohort design with telephone interviews and clinical examinations.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>SETTING:<\/jats:bold>\n                    Managed care provider groups that contract with one large network\u2010model health plan in Los Angeles County.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>PARTICIPANTS:<\/jats:bold>\n                    A random sample of community\u2010dwelling Medicare beneficiaries with diabetes mellitus aged 65 and older covered by the same pharmacy benefit.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>MEASUREMENTS:<\/jats:bold>\n                    Patients reported their sociodemographic and clinical characteristics. Annual household income (\u2265$20,000 or &lt;$20,000) was the primary predictor. The outcome variable was use of evidence\u2010based therapies determined by a review of all current medications brought to the clinical examination. The medications studied included use of any cholesterol\u2010lowering medications, use of 3\u2010hydroxy\u20103\u2010methylglutaryl coenzyme A reductase inhibitors (statins) for cholesterol lowering, aspirin for primary and secondary prevention of cardiovascular disease, and angiotensin\u2010converting enzyme (ACE) inhibitors in those with diabetic nephropathy. The influence of income on evidence\u2010based medication use was adjusted for other patient characteristics.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>RESULTS:<\/jats:bold>\n                    The cohort consisted of 301 persons with diabetes mellitus, of whom 53% had annual household income under $20,000. In unadjusted analyses, there were lower rates of use of all evidence\u2010based therapies and lower rates of statin use for persons with annual income under $20,000 than for higher\u2010income persons. In multivariate models, statin use was observed in 57% of higher\u2010income versus 30% of lower\u2010income respondents with a history of hyperlipidemia (\n                    <jats:italic>P<\/jats:italic>\n                    = .01) and 66% of higher\u2010income versus 29% of lower\u2010income respondents with a history of myocardial infarction (\n                    <jats:italic>P<\/jats:italic>\n                    = .03). There were no differences by income in the rates of aspirin or ACE inhibitor use.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>CONCLUSION:<\/jats:bold>\n                    Among these Medicare managed care beneficiaries with diabetes mellitus, all of whom had the same pharmacy benefit, there were low rates of use of evidence\u2010based therapies overall and substantially lower use of statins by poorer persons.\n                  <\/jats:p>","DOI":"10.1034\/j.1600-0579.2003.00211.x","type":"journal-article","created":{"date-parts":[[2004,12,27]],"date-time":"2004-12-27T03:20:09Z","timestamp":1104117609000},"page":"665-670","source":"Crossref","is-referenced-by-count":87,"title":["Income\u2010Related Differences in the Use of Evidence\u2010Based Therapies in Older Persons with Diabetes Mellitus in For\u2010Profit Managed Care"],"prefix":"10.1034","volume":"51","author":[{"given":"Arleen F.","family":"Brown","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy G.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter R.","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luohua","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin F.","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol M.","family":"Mangione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,4,29]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.25.1.213"},{"issue":"3","key":"e_1_2_6_3_2","first-page":"6","article-title":"Risk factors for macrovascular disease in type 2 diabetes. Classic lipid abnormalities.","volume":"22","author":"Steiner G","year":"1999","journal-title":"Diabetes Care"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.21.4.641"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199610033351401"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.20.4.614"},{"key":"e_1_2_6_7_2","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1001\/jama.1992.03490100090033","article-title":"Aspirin effects on mortality and morbidity in patients with diabetes mellitus. Early Treatment Diabetic Retinopathy Study report 14.","volume":"268","author":"EDTRS Investigators","year":"1992","journal-title":"JAMA"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199311113292004"},{"key":"e_1_2_6_9_2","first-page":"939","article-title":"Effect of the angiotensin\u2010converting\u2010enzyme inhibitor benazepril on the progression of chronic renal insufficiency.","volume":"334","author":"Maschio G","journal-title":"The Angiotensin-Converting Enzyme Inhibition"},{"key":"e_1_2_6_10_2","doi-asserted-by":"crossref","unstructured":"Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39 UK Prospective Diabetes Study Group. BMJ 1998;317:713\u2013720.","DOI":"10.1136\/bmj.317.7160.713"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)12323-7"},{"key":"e_1_2_6_12_2","first-page":"1761","article-title":"Time trends in the use of cholesterol\u2010lowering agents in older adults.","volume":"158","author":"Lemaitre RN","year":"1998","journal-title":"The Cardiovascular Health Study. Arch Intern Med"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.161.2.183"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.92.10.2841"},{"key":"e_1_2_6_15_2","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1001\/archinte.1996.00440070131015","article-title":"Adherence to national guidelines for drug treatment of suspected acute myocardial infarction: Evidence for undertreatment in women and the elderly.","volume":"156","author":"McLaughlin TJ","year":"1996","journal-title":"Arch Intern Med"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.1999.tb04571.x"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.publhealth.22.1.49"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.20.1.276"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.14.1732"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199409083311006"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-199601000-00006"},{"key":"e_1_2_6_22_2","volume-title":"How to Score the SF\u201012 Physical and Mental Health Summary Scale","author":"Ware JE","year":"1995"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011161"},{"key":"e_1_2_6_24_2","volume-title":"Introduction to the Theory of Statistics","author":"Moon AMGFA","year":"1963"},{"key":"e_1_2_6_25_2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1001\/jama.1997.03540260029031","article-title":"Adverse outcomes of underuse of beta\u2010blockers in elderly survivors of acute myocardial infarction.","volume":"277","author":"Soumerai SB","year":"1997","journal-title":"JAMA"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-198408000-00004"},{"key":"e_1_2_6_27_2","first-page":"396","article-title":"The differential impact of copayment on drug use in a Medicaid population.","volume":"22","author":"Reeder CE","year":"1985","journal-title":"Inquiry"},{"key":"e_1_2_6_28_2","first-page":"241","article-title":"Out\u2010of\u2010pocket health spending by poor and near\u2010poor elderly Medicare beneficiaries.","volume":"34","author":"Gross DJ","year":"1999","journal-title":"Health Serv Res"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.20.4.120"},{"key":"e_1_2_6_30_2","volume-title":"A Side\u2010by\u2010Side Comparison of Selected Medicare Prescription Drug Coverage Proposals","author":"Gluck M","year":"1999"}],"container-title":["Journal of the American Geriatrics Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-0579.2003.00211.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1034\/j.1600-0579.2003.00211.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T18:39:40Z","timestamp":1762195180000},"score":1,"resource":{"primary":{"URL":"https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/10.1034\/j.1600-0579.2003.00211.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,4,29]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,5]]}},"alternative-id":["10.1034\/j.1600-0579.2003.00211.x"],"URL":"https:\/\/doi.org\/10.1034\/j.1600-0579.2003.00211.x","archive":["Portico"],"relation":{},"ISSN":["0002-8614","1532-5415"],"issn-type":[{"value":"0002-8614","type":"print"},{"value":"1532-5415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,4,29]]}}}